Loading…
Nitrergic inhibition of sympathetic arteriolar constrictions in the female rodent urethra
During the urine storage phase, tonically contracting urethral musculature would have a higher energy consumption than bladder muscle that develops phasic contractions. However, ischaemic dysfunction is less prevalent in the urethra than in the bladder, suggesting that urethral vasculature has intri...
Saved in:
Published in: | The Journal of physiology 2024-05, Vol.602 (10), p.2199-2226 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c3117-740dfe1b61e7123621398495e4849b6291786f98058de578fa5f62389c00a5d23 |
container_end_page | 2226 |
container_issue | 10 |
container_start_page | 2199 |
container_title | The Journal of physiology |
container_volume | 602 |
creator | Hashitani, Hikaru Mitsui, Retsu Hirai, Yuuna Tanaka, Hidekazu Miwa‐Nishimura, Kyoko |
description | During the urine storage phase, tonically contracting urethral musculature would have a higher energy consumption than bladder muscle that develops phasic contractions. However, ischaemic dysfunction is less prevalent in the urethra than in the bladder, suggesting that urethral vasculature has intrinsic properties ensuring an adequate blood supply. Diameter changes in rat or mouse urethral arterioles were measured using a video‐tracking system. Intercellular Ca2+ dynamics in arteriolar smooth muscle (SMCs) and endothelial cells were visualised using NG2‐ and parvalbumin‐GCaMP6 mice, respectively. Fluorescence immunohistochemistry was used to visualise the perivascular innervation. In rat urethral arterioles, sympathetic vasoconstrictions were predominantly suppressed by α,β‐methylene ATP (10 μM) but not prazosin (1 μM). Tadalafil (100 nM), a PDE5 inhibitor, diminished the vasoconstrictions in a manner reversed by N‐ω‐propyl‐l‐arginine hydrochloride (l‐NPA, 1 μM), a neuronal NO synthesis (nNOS) inhibitor. Vesicular acetylcholine transporter immunoreactive perivascular nerve fibres co‐expressing nNOS were intertwined with tyrosine hydroxylase immunoreactive sympathetic nerve fibres. In phenylephrine (1 μM) pre‐constricted rat or mouse urethral arterioles, nerve‐evoked vasodilatations or transient SMC Ca2+ reductions were largely diminished by l‐nitroarginine (l‐NA, 10 μM), a broad‐spectrum NOS inhibitor, but not by l‐NPA. The CGRP receptor antagonist BIBN‐4096 (1 μM) shortened the vasodilatory responses, while atropine (1 μM) abolished the l‐NA‐resistant transient vasodilatory responses. Nerve‐evoked endothelial Ca2+ transients were abolished by atropine plus guanethidine (10 μM), indicating its neurotransmitter origin and absence of non‐adrenergic non‐cholinergic endothelial NO release. In urethral arterioles, NO released from parasympathetic nerves counteracts sympathetic vasoconstrictions pre‐ and post‐synaptically to restrict arteriolar contractility.
Key points
Despite a higher energy consumption of the urethral musculature than the bladder detrusor muscle, ischaemic dysfunction of the urethra is less prevalent than that of the bladder.
In the urethral arterioles, sympathetic vasoconstrictions are predominately mediated by ATP, not noradrenaline.
NO released from parasympathetic nerves counteracts sympathetic vasoconstrictions by its pre‐synaptic inhibition of sympathetic transmission as well as post‐synaptic arteriolar smooth muscle relaxation.
Acetylc |
doi_str_mv | 10.1113/JP285583 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3046511487</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3054743087</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3117-740dfe1b61e7123621398495e4849b6291786f98058de578fa5f62389c00a5d23</originalsourceid><addsrcrecordid>eNp10D1P5DAQBmALcYKFQ-IXoEg0NOE88XeJEB-H0B3FXkEVeZMJa5TEi-0I7b_HsMsVSDSews-8Gr2EHAM9BwD26-6h0kJotkNmwKUplTJsl8woraqSKQH75CDGZ0qBUWP2yD7TUkjF1Yw8_nEpYHhyTeHGpVu45PxY-K6I62Fl0xJT_rEhYXC-t6Fo_BhTcM07i3mlyKTocLA9FsG3OKZiCpiWwf4kPzrbRzzazkPy7_pqfnlb3v-9-X15cV82DECVitO2Q1hIQAUVkxUwo7kRyPO7kJUBpWVnNBW6RaF0Z0UnK6ZNQ6kVbcUOydkmdxX8y4Qx1YOLDfa9HdFPsWaUSwHAtcr09At99lMY83VZCa44ox9qG9gEH2PArl4FN9iwroHW73XXn3VnerINnBYDtv_hZ78ZnG_Aq-tx_W1QPb97AEmFYm8o5oao</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3054743087</pqid></control><display><type>article</type><title>Nitrergic inhibition of sympathetic arteriolar constrictions in the female rodent urethra</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Hashitani, Hikaru ; Mitsui, Retsu ; Hirai, Yuuna ; Tanaka, Hidekazu ; Miwa‐Nishimura, Kyoko</creator><creatorcontrib>Hashitani, Hikaru ; Mitsui, Retsu ; Hirai, Yuuna ; Tanaka, Hidekazu ; Miwa‐Nishimura, Kyoko</creatorcontrib><description>During the urine storage phase, tonically contracting urethral musculature would have a higher energy consumption than bladder muscle that develops phasic contractions. However, ischaemic dysfunction is less prevalent in the urethra than in the bladder, suggesting that urethral vasculature has intrinsic properties ensuring an adequate blood supply. Diameter changes in rat or mouse urethral arterioles were measured using a video‐tracking system. Intercellular Ca2+ dynamics in arteriolar smooth muscle (SMCs) and endothelial cells were visualised using NG2‐ and parvalbumin‐GCaMP6 mice, respectively. Fluorescence immunohistochemistry was used to visualise the perivascular innervation. In rat urethral arterioles, sympathetic vasoconstrictions were predominantly suppressed by α,β‐methylene ATP (10 μM) but not prazosin (1 μM). Tadalafil (100 nM), a PDE5 inhibitor, diminished the vasoconstrictions in a manner reversed by N‐ω‐propyl‐l‐arginine hydrochloride (l‐NPA, 1 μM), a neuronal NO synthesis (nNOS) inhibitor. Vesicular acetylcholine transporter immunoreactive perivascular nerve fibres co‐expressing nNOS were intertwined with tyrosine hydroxylase immunoreactive sympathetic nerve fibres. In phenylephrine (1 μM) pre‐constricted rat or mouse urethral arterioles, nerve‐evoked vasodilatations or transient SMC Ca2+ reductions were largely diminished by l‐nitroarginine (l‐NA, 10 μM), a broad‐spectrum NOS inhibitor, but not by l‐NPA. The CGRP receptor antagonist BIBN‐4096 (1 μM) shortened the vasodilatory responses, while atropine (1 μM) abolished the l‐NA‐resistant transient vasodilatory responses. Nerve‐evoked endothelial Ca2+ transients were abolished by atropine plus guanethidine (10 μM), indicating its neurotransmitter origin and absence of non‐adrenergic non‐cholinergic endothelial NO release. In urethral arterioles, NO released from parasympathetic nerves counteracts sympathetic vasoconstrictions pre‐ and post‐synaptically to restrict arteriolar contractility.
Key points
Despite a higher energy consumption of the urethral musculature than the bladder detrusor muscle, ischaemic dysfunction of the urethra is less prevalent than that of the bladder.
In the urethral arterioles, sympathetic vasoconstrictions are predominately mediated by ATP, not noradrenaline.
NO released from parasympathetic nerves counteracts sympathetic vasoconstrictions by its pre‐synaptic inhibition of sympathetic transmission as well as post‐synaptic arteriolar smooth muscle relaxation.
Acetylcholine released from parasympathetic nerves contributes to endothelium‐dependent, transient vasodilatations, while CGRP released from sensory nerves prolongs NO‐mediated vasodilatations.
PDE5 inhibitors could be beneficial to maintain and/or improve urethral blood supply and in turn the volume and contractility of urethral musculature.
figure legend Ischaemia is a major cause of lower urinary tract symptoms (LUTS), but ischaemic dysfunction is less prevalent in the urethra than in the bladder. In the bladder, sympathetic overdrive associated with ageing or metabolic syndrome would constrict arteries/arterioles resulting in blood flow reduction. In the urethra, parasympathetic and sensory nerves well counteract sympathetic vasoconstriction to minimise blood flow reduction. NO released from parasympathetic nerves diminishes sympathetic transmitter release, while directly relaxing arteriolar smooth muscle cells. Acetylcholine (ACh) also contributes to parasympathetic vasodilatation presumably by stimulating endothelium‐dependent hyperpolarisation. CGRP released from sensory nerves is capable of inducing arteriolar dilatation by an NO‐independent mechanism.</description><identifier>ISSN: 0022-3751</identifier><identifier>EISSN: 1469-7793</identifier><identifier>DOI: 10.1113/JP285583</identifier><identifier>PMID: 38656747</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Acetylcholine ; Animals ; Arterioles ; Arterioles - drug effects ; Arterioles - metabolism ; Arterioles - physiology ; Atropine ; Bladder ; Calcitonin gene-related peptide ; Calcium signalling ; CGRP ; Endothelial cells ; Endothelium ; Energy consumption ; Female ; Immunohistochemistry ; Innervation ; Ischemia ; Mice ; Mice, Inbred C57BL ; Muscle contraction ; nitric oxide ; Norepinephrine ; parasympathetic nerve ; Parasympathetic nervous system ; Parvalbumin ; Phenylephrine ; Prazosin ; Rats ; Rats, Sprague-Dawley ; Sensory neurons ; Smooth muscle ; sympathetic nerve ; Sympathetic nerves ; Sympathetic Nervous System - drug effects ; Sympathetic Nervous System - physiology ; Synaptic transmission ; Tyrosine 3-monooxygenase ; Urethra ; Urethra - drug effects ; Urethra - innervation ; Urethra - physiology ; Vasoconstriction - drug effects ; Vesicular acetylcholine transporter</subject><ispartof>The Journal of physiology, 2024-05, Vol.602 (10), p.2199-2226</ispartof><rights>2024 The Authors. © 2024 The Physiological Society.</rights><rights>2024 The Authors. The Journal of Physiology © 2024 The Physiological Society.</rights><rights>Journal compilation © 2024 The Physiological Society.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3117-740dfe1b61e7123621398495e4849b6291786f98058de578fa5f62389c00a5d23</cites><orcidid>0000-0002-3877-4349 ; 0000-0003-2932-4693</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38656747$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hashitani, Hikaru</creatorcontrib><creatorcontrib>Mitsui, Retsu</creatorcontrib><creatorcontrib>Hirai, Yuuna</creatorcontrib><creatorcontrib>Tanaka, Hidekazu</creatorcontrib><creatorcontrib>Miwa‐Nishimura, Kyoko</creatorcontrib><title>Nitrergic inhibition of sympathetic arteriolar constrictions in the female rodent urethra</title><title>The Journal of physiology</title><addtitle>J Physiol</addtitle><description>During the urine storage phase, tonically contracting urethral musculature would have a higher energy consumption than bladder muscle that develops phasic contractions. However, ischaemic dysfunction is less prevalent in the urethra than in the bladder, suggesting that urethral vasculature has intrinsic properties ensuring an adequate blood supply. Diameter changes in rat or mouse urethral arterioles were measured using a video‐tracking system. Intercellular Ca2+ dynamics in arteriolar smooth muscle (SMCs) and endothelial cells were visualised using NG2‐ and parvalbumin‐GCaMP6 mice, respectively. Fluorescence immunohistochemistry was used to visualise the perivascular innervation. In rat urethral arterioles, sympathetic vasoconstrictions were predominantly suppressed by α,β‐methylene ATP (10 μM) but not prazosin (1 μM). Tadalafil (100 nM), a PDE5 inhibitor, diminished the vasoconstrictions in a manner reversed by N‐ω‐propyl‐l‐arginine hydrochloride (l‐NPA, 1 μM), a neuronal NO synthesis (nNOS) inhibitor. Vesicular acetylcholine transporter immunoreactive perivascular nerve fibres co‐expressing nNOS were intertwined with tyrosine hydroxylase immunoreactive sympathetic nerve fibres. In phenylephrine (1 μM) pre‐constricted rat or mouse urethral arterioles, nerve‐evoked vasodilatations or transient SMC Ca2+ reductions were largely diminished by l‐nitroarginine (l‐NA, 10 μM), a broad‐spectrum NOS inhibitor, but not by l‐NPA. The CGRP receptor antagonist BIBN‐4096 (1 μM) shortened the vasodilatory responses, while atropine (1 μM) abolished the l‐NA‐resistant transient vasodilatory responses. Nerve‐evoked endothelial Ca2+ transients were abolished by atropine plus guanethidine (10 μM), indicating its neurotransmitter origin and absence of non‐adrenergic non‐cholinergic endothelial NO release. In urethral arterioles, NO released from parasympathetic nerves counteracts sympathetic vasoconstrictions pre‐ and post‐synaptically to restrict arteriolar contractility.
Key points
Despite a higher energy consumption of the urethral musculature than the bladder detrusor muscle, ischaemic dysfunction of the urethra is less prevalent than that of the bladder.
In the urethral arterioles, sympathetic vasoconstrictions are predominately mediated by ATP, not noradrenaline.
NO released from parasympathetic nerves counteracts sympathetic vasoconstrictions by its pre‐synaptic inhibition of sympathetic transmission as well as post‐synaptic arteriolar smooth muscle relaxation.
Acetylcholine released from parasympathetic nerves contributes to endothelium‐dependent, transient vasodilatations, while CGRP released from sensory nerves prolongs NO‐mediated vasodilatations.
PDE5 inhibitors could be beneficial to maintain and/or improve urethral blood supply and in turn the volume and contractility of urethral musculature.
figure legend Ischaemia is a major cause of lower urinary tract symptoms (LUTS), but ischaemic dysfunction is less prevalent in the urethra than in the bladder. In the bladder, sympathetic overdrive associated with ageing or metabolic syndrome would constrict arteries/arterioles resulting in blood flow reduction. In the urethra, parasympathetic and sensory nerves well counteract sympathetic vasoconstriction to minimise blood flow reduction. NO released from parasympathetic nerves diminishes sympathetic transmitter release, while directly relaxing arteriolar smooth muscle cells. Acetylcholine (ACh) also contributes to parasympathetic vasodilatation presumably by stimulating endothelium‐dependent hyperpolarisation. CGRP released from sensory nerves is capable of inducing arteriolar dilatation by an NO‐independent mechanism.</description><subject>Acetylcholine</subject><subject>Animals</subject><subject>Arterioles</subject><subject>Arterioles - drug effects</subject><subject>Arterioles - metabolism</subject><subject>Arterioles - physiology</subject><subject>Atropine</subject><subject>Bladder</subject><subject>Calcitonin gene-related peptide</subject><subject>Calcium signalling</subject><subject>CGRP</subject><subject>Endothelial cells</subject><subject>Endothelium</subject><subject>Energy consumption</subject><subject>Female</subject><subject>Immunohistochemistry</subject><subject>Innervation</subject><subject>Ischemia</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Muscle contraction</subject><subject>nitric oxide</subject><subject>Norepinephrine</subject><subject>parasympathetic nerve</subject><subject>Parasympathetic nervous system</subject><subject>Parvalbumin</subject><subject>Phenylephrine</subject><subject>Prazosin</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Sensory neurons</subject><subject>Smooth muscle</subject><subject>sympathetic nerve</subject><subject>Sympathetic nerves</subject><subject>Sympathetic Nervous System - drug effects</subject><subject>Sympathetic Nervous System - physiology</subject><subject>Synaptic transmission</subject><subject>Tyrosine 3-monooxygenase</subject><subject>Urethra</subject><subject>Urethra - drug effects</subject><subject>Urethra - innervation</subject><subject>Urethra - physiology</subject><subject>Vasoconstriction - drug effects</subject><subject>Vesicular acetylcholine transporter</subject><issn>0022-3751</issn><issn>1469-7793</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp10D1P5DAQBmALcYKFQ-IXoEg0NOE88XeJEB-H0B3FXkEVeZMJa5TEi-0I7b_HsMsVSDSews-8Gr2EHAM9BwD26-6h0kJotkNmwKUplTJsl8woraqSKQH75CDGZ0qBUWP2yD7TUkjF1Yw8_nEpYHhyTeHGpVu45PxY-K6I62Fl0xJT_rEhYXC-t6Fo_BhTcM07i3mlyKTocLA9FsG3OKZiCpiWwf4kPzrbRzzazkPy7_pqfnlb3v-9-X15cV82DECVitO2Q1hIQAUVkxUwo7kRyPO7kJUBpWVnNBW6RaF0Z0UnK6ZNQ6kVbcUOydkmdxX8y4Qx1YOLDfa9HdFPsWaUSwHAtcr09At99lMY83VZCa44ox9qG9gEH2PArl4FN9iwroHW73XXn3VnerINnBYDtv_hZ78ZnG_Aq-tx_W1QPb97AEmFYm8o5oao</recordid><startdate>20240501</startdate><enddate>20240501</enddate><creator>Hashitani, Hikaru</creator><creator>Mitsui, Retsu</creator><creator>Hirai, Yuuna</creator><creator>Tanaka, Hidekazu</creator><creator>Miwa‐Nishimura, Kyoko</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>7TS</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-3877-4349</orcidid><orcidid>https://orcid.org/0000-0003-2932-4693</orcidid></search><sort><creationdate>20240501</creationdate><title>Nitrergic inhibition of sympathetic arteriolar constrictions in the female rodent urethra</title><author>Hashitani, Hikaru ; Mitsui, Retsu ; Hirai, Yuuna ; Tanaka, Hidekazu ; Miwa‐Nishimura, Kyoko</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3117-740dfe1b61e7123621398495e4849b6291786f98058de578fa5f62389c00a5d23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Acetylcholine</topic><topic>Animals</topic><topic>Arterioles</topic><topic>Arterioles - drug effects</topic><topic>Arterioles - metabolism</topic><topic>Arterioles - physiology</topic><topic>Atropine</topic><topic>Bladder</topic><topic>Calcitonin gene-related peptide</topic><topic>Calcium signalling</topic><topic>CGRP</topic><topic>Endothelial cells</topic><topic>Endothelium</topic><topic>Energy consumption</topic><topic>Female</topic><topic>Immunohistochemistry</topic><topic>Innervation</topic><topic>Ischemia</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Muscle contraction</topic><topic>nitric oxide</topic><topic>Norepinephrine</topic><topic>parasympathetic nerve</topic><topic>Parasympathetic nervous system</topic><topic>Parvalbumin</topic><topic>Phenylephrine</topic><topic>Prazosin</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Sensory neurons</topic><topic>Smooth muscle</topic><topic>sympathetic nerve</topic><topic>Sympathetic nerves</topic><topic>Sympathetic Nervous System - drug effects</topic><topic>Sympathetic Nervous System - physiology</topic><topic>Synaptic transmission</topic><topic>Tyrosine 3-monooxygenase</topic><topic>Urethra</topic><topic>Urethra - drug effects</topic><topic>Urethra - innervation</topic><topic>Urethra - physiology</topic><topic>Vasoconstriction - drug effects</topic><topic>Vesicular acetylcholine transporter</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hashitani, Hikaru</creatorcontrib><creatorcontrib>Mitsui, Retsu</creatorcontrib><creatorcontrib>Hirai, Yuuna</creatorcontrib><creatorcontrib>Tanaka, Hidekazu</creatorcontrib><creatorcontrib>Miwa‐Nishimura, Kyoko</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Physical Education Index</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of physiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hashitani, Hikaru</au><au>Mitsui, Retsu</au><au>Hirai, Yuuna</au><au>Tanaka, Hidekazu</au><au>Miwa‐Nishimura, Kyoko</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Nitrergic inhibition of sympathetic arteriolar constrictions in the female rodent urethra</atitle><jtitle>The Journal of physiology</jtitle><addtitle>J Physiol</addtitle><date>2024-05-01</date><risdate>2024</risdate><volume>602</volume><issue>10</issue><spage>2199</spage><epage>2226</epage><pages>2199-2226</pages><issn>0022-3751</issn><eissn>1469-7793</eissn><abstract>During the urine storage phase, tonically contracting urethral musculature would have a higher energy consumption than bladder muscle that develops phasic contractions. However, ischaemic dysfunction is less prevalent in the urethra than in the bladder, suggesting that urethral vasculature has intrinsic properties ensuring an adequate blood supply. Diameter changes in rat or mouse urethral arterioles were measured using a video‐tracking system. Intercellular Ca2+ dynamics in arteriolar smooth muscle (SMCs) and endothelial cells were visualised using NG2‐ and parvalbumin‐GCaMP6 mice, respectively. Fluorescence immunohistochemistry was used to visualise the perivascular innervation. In rat urethral arterioles, sympathetic vasoconstrictions were predominantly suppressed by α,β‐methylene ATP (10 μM) but not prazosin (1 μM). Tadalafil (100 nM), a PDE5 inhibitor, diminished the vasoconstrictions in a manner reversed by N‐ω‐propyl‐l‐arginine hydrochloride (l‐NPA, 1 μM), a neuronal NO synthesis (nNOS) inhibitor. Vesicular acetylcholine transporter immunoreactive perivascular nerve fibres co‐expressing nNOS were intertwined with tyrosine hydroxylase immunoreactive sympathetic nerve fibres. In phenylephrine (1 μM) pre‐constricted rat or mouse urethral arterioles, nerve‐evoked vasodilatations or transient SMC Ca2+ reductions were largely diminished by l‐nitroarginine (l‐NA, 10 μM), a broad‐spectrum NOS inhibitor, but not by l‐NPA. The CGRP receptor antagonist BIBN‐4096 (1 μM) shortened the vasodilatory responses, while atropine (1 μM) abolished the l‐NA‐resistant transient vasodilatory responses. Nerve‐evoked endothelial Ca2+ transients were abolished by atropine plus guanethidine (10 μM), indicating its neurotransmitter origin and absence of non‐adrenergic non‐cholinergic endothelial NO release. In urethral arterioles, NO released from parasympathetic nerves counteracts sympathetic vasoconstrictions pre‐ and post‐synaptically to restrict arteriolar contractility.
Key points
Despite a higher energy consumption of the urethral musculature than the bladder detrusor muscle, ischaemic dysfunction of the urethra is less prevalent than that of the bladder.
In the urethral arterioles, sympathetic vasoconstrictions are predominately mediated by ATP, not noradrenaline.
NO released from parasympathetic nerves counteracts sympathetic vasoconstrictions by its pre‐synaptic inhibition of sympathetic transmission as well as post‐synaptic arteriolar smooth muscle relaxation.
Acetylcholine released from parasympathetic nerves contributes to endothelium‐dependent, transient vasodilatations, while CGRP released from sensory nerves prolongs NO‐mediated vasodilatations.
PDE5 inhibitors could be beneficial to maintain and/or improve urethral blood supply and in turn the volume and contractility of urethral musculature.
figure legend Ischaemia is a major cause of lower urinary tract symptoms (LUTS), but ischaemic dysfunction is less prevalent in the urethra than in the bladder. In the bladder, sympathetic overdrive associated with ageing or metabolic syndrome would constrict arteries/arterioles resulting in blood flow reduction. In the urethra, parasympathetic and sensory nerves well counteract sympathetic vasoconstriction to minimise blood flow reduction. NO released from parasympathetic nerves diminishes sympathetic transmitter release, while directly relaxing arteriolar smooth muscle cells. Acetylcholine (ACh) also contributes to parasympathetic vasodilatation presumably by stimulating endothelium‐dependent hyperpolarisation. CGRP released from sensory nerves is capable of inducing arteriolar dilatation by an NO‐independent mechanism.</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>38656747</pmid><doi>10.1113/JP285583</doi><tpages>28</tpages><orcidid>https://orcid.org/0000-0002-3877-4349</orcidid><orcidid>https://orcid.org/0000-0003-2932-4693</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-3751 |
ispartof | The Journal of physiology, 2024-05, Vol.602 (10), p.2199-2226 |
issn | 0022-3751 1469-7793 |
language | eng |
recordid | cdi_proquest_miscellaneous_3046511487 |
source | Wiley-Blackwell Read & Publish Collection |
subjects | Acetylcholine Animals Arterioles Arterioles - drug effects Arterioles - metabolism Arterioles - physiology Atropine Bladder Calcitonin gene-related peptide Calcium signalling CGRP Endothelial cells Endothelium Energy consumption Female Immunohistochemistry Innervation Ischemia Mice Mice, Inbred C57BL Muscle contraction nitric oxide Norepinephrine parasympathetic nerve Parasympathetic nervous system Parvalbumin Phenylephrine Prazosin Rats Rats, Sprague-Dawley Sensory neurons Smooth muscle sympathetic nerve Sympathetic nerves Sympathetic Nervous System - drug effects Sympathetic Nervous System - physiology Synaptic transmission Tyrosine 3-monooxygenase Urethra Urethra - drug effects Urethra - innervation Urethra - physiology Vasoconstriction - drug effects Vesicular acetylcholine transporter |
title | Nitrergic inhibition of sympathetic arteriolar constrictions in the female rodent urethra |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T11%3A09%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Nitrergic%20inhibition%20of%20sympathetic%20arteriolar%20constrictions%20in%20the%20female%20rodent%20urethra&rft.jtitle=The%20Journal%20of%20physiology&rft.au=Hashitani,%20Hikaru&rft.date=2024-05-01&rft.volume=602&rft.issue=10&rft.spage=2199&rft.epage=2226&rft.pages=2199-2226&rft.issn=0022-3751&rft.eissn=1469-7793&rft_id=info:doi/10.1113/JP285583&rft_dat=%3Cproquest_cross%3E3054743087%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3117-740dfe1b61e7123621398495e4849b6291786f98058de578fa5f62389c00a5d23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3054743087&rft_id=info:pmid/38656747&rfr_iscdi=true |